Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–7 of 7 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
NCT05077527
- Conditions
- AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, Blood-Borne Infections, +36 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Illinois at Chicago Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
NCT05873712
- Conditions
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Recurrent Transformed Non-Hodgkin Lymphoma, +5 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT02207062
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03309878
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
NCT03277729
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +43 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT04665765
- Conditions
- Diffuse Large B-Cell Lymphoma Unclassifiable, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Atlanta, Georgia, United States
Active, Not Recruiting
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
NCT05202782
- Conditions
- Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +27 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States